Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada

Gardado en:

Detalles Bibliográficos
Autor Principal:	Pilarinos, A.
Outros autores:	et al
Formato:	Libro
Idioma:	Lingua castelá inglés
Subjects:	Drogodependencias Juventud Adolescentes Consumo Heroína Tratamiento Reducción de daños Acceso Barreras Factor de protección Factor de riesgo Actitudes usuarios Experiencias Evaluación de servicios Canadá Adicciones Menores Documental
Acceso en liña:	Path Enlace web
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares: Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada

Quick Look
The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
Quick Look
AGONIST OPIOID TREATMENT IN PRISONS
Quick Look
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada
Quick Look
Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
Quick Look
Community led monitoring of opioid agonist treatment including WHO quality of life indicators
Quick Look
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study
Quick Look
Risk factors for relapse and higher costs among medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history
Quick Look
DECREASING INTERNATIONAL HIV TRANSMISSION: THE ROLE OF EXPANDING ACCESS TO OPIOID AGONIST THERAPIES FOR INJECTION DRUG USERS
Quick Look
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study
Quick Look
Opioid agonist treatment. Guiding principles for legislation and regulations
Quick Look
Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study
Quick Look
SLEEP PROBLEMS REPORTED BY PATIENTS ENTERING OPIOID AGONIST TREATMENT
Quick Look
Dose–response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids
Quick Look
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials
Quick Look
ILLICIT USE OF OPIOIDS: IS OXYCONTIN A GATEWAY DRUG?
Quick Look
Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals
Quick Look
“As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids
Quick Look
Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic
Quick Look
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial
Quick Look
Education as drug policy: A realist synthesis of continuing professional development for opioid agonist therapy
Quick Look
INFORMED CONSENT TO OPIOID AGONIST MAINTENANCE TREATMENT: RECOMMENDED ETHICAL GUIDELINES
Quick Look
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
Quick Look
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
Quick Look
TIME LIMITED BUPRENORPHINE REPLACEMENT THERAPY FOR OPIOID DEPENDENCE: 2 YEAR FOLLOW UP OUCOMES IN RELATION TO PROGRAMME COMPLETION AND CURRENT AGONIST THERAPY STATUS